Additional Therapy with a Mistletoe Product during Adjuvant Chemotherapy of Breast Cancer Patients Improves Quality of Life: An Open Randomized Clinical Pilot Trial

Table 2

Number of patients and compliance in the completion of QoL forms by visit and groups.

Group Visit	Time schedule (days)	Time window (days)	Dropout	Forms expected	Forms received
Control
1	0	0-0	0	31	29 (94%)
2	21	21–25	0	31	31 (100%)
3	42	42–49	0	31	31 (100%)
4	63	63–74	1	30	30 (100%)
5	84	84–98	1	30	30 (100%)
6	105	105–122	1	30	30 (100%)
7	182≥𝑥≥26	126–143	1	30	30 (100%)
Helixor:
1	0	0-0	0	34	34 (100%)
2	21	18–28	2	32	32 (100%)
3	42	39–51	5	29	29 (100%)
4	63	63–75	5	29	29 (100%)
5	84	84–96	5	29	29 (100%)
6	105	105–117	5	29	29 (100%)
7	182≥𝑥≥126	126–155	5	29	29 (100%)